Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Actual shortage 2024-11-11 2026-04-13 242762
SANDOZ TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2019-12-10 2020-01-22 100856
SANDOZ TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2024-09-30 2024-12-24 238952
SANDOZ TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2019-09-10 2019-11-06 93428
SANDOZ TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2017-11-14 2017-11-27 29183
SANDOZ TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2024-09-16 2024-12-24 237757
SANDOZ TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2017-11-14 2017-11-27 29180
SANDOZ TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Actual shortage 2025-04-28 2026-04-13 255907
SANDOZ TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Actual shortage 2025-06-23 2026-04-13 260902
SANDOZ TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2024-07-29 2024-11-05 233875
SANDOZ TOPIRAMATE TABLETS 200MG TABLET Resolved 2017-07-24 2018-11-13 16757
SANDOZ TOPIRAMATE TABLETS 25MG TABLET Resolved 2022-05-10 2022-05-24 160303
SANDOZ TOPIRAMATE TABLETS 25MG TABLET Resolved 2018-08-29 2018-11-13 59525
SANDOZ TOPIRAMATE TABLETS 200MG TABLET Resolved 2021-01-18 2021-03-02 131836
SANDOZ TOPIRAMATE TABLETS 100MG TABLET Resolved 2017-11-14 2018-11-13 29192
SANDOZ TOPIRAMATE TABLETS 25MG TABLET Resolved 2021-01-12 2021-03-02 131414
SANDOZ TOPIRAMATE TABLETS 200MG TABLET Resolved 2022-05-10 2022-05-24 160306
SANDOZ TOPIRAMATE TABLETS 100MG TABLET Resolved 2022-05-10 2022-05-24 160300
SANDOZ TOPIRAMATE TABLETS 100MG TABLET Resolved 2021-01-12 2021-03-02 131411
SANDOZ TRAMADOL 50MG TABLET Resolved 2021-11-29 2021-12-21 150158
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ANGIOMAX 250MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280590
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BORTEZOMIB FOR INJECTION SDZ 3.5MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280595
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265

Showing 1 to 20 of 136